REGENXBIO Inc. (RGNX)
NASDAQ: RGNX
· Real-Time Price · USD
8.72
-0.10 (-1.13%)
At close: Aug 18, 2025, 3:59 PM
8.60
-1.43%
After-hours: Aug 18, 2025, 05:36 PM EDT
REGENXBIO Revenue
REGENXBIO reported an annual revenue of $83.33M, reflecting a -7.66% growth. For the quarter ending June 30, 2025, REGENXBIO generated $21.36M in revenue.
Revenue (ttm)
83.33M
Revenue Growth
-7.66%
Price / Sales Ratio
4.59
Revenue / Employee
236.06K
Employees
353
Market Cap
440.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 83.33M | -7.66% |
| Dec 31, 2023 | 90.24M | -19.94% |
| Dec 31, 2022 | 112.72M | -76.03% |
| Dec 31, 2021 | 470.35M | +204.30% |
| Dec 31, 2020 | 154.57M | +338.70% |
| Dec 31, 2019 | 35.23M | -83.88% |
| Dec 31, 2018 | 218.5M | +2002.42% |
| Dec 31, 2017 | 10.39M | +126.48% |
| Dec 31, 2016 | 4.59M | -39.52% |
| Dec 31, 2015 | 7.59M | +23.99% |
| Dec 31, 2014 | 6.12M | +0.54% |
| Dec 31, 2013 | 6.09M | n/a |